Skip to main content
Earnings Labs
Evogene Ltd. logo

Evogene Ltd. (EVGN)

NASDAQ·Healthcare·Biotechnology

$0.55

-1.54%

Mkt Cap $6.67M

Analyst Ratings

No recent rating data.

Price Target (3 analysts)

$2.15

Range $2.15$2.15

Implied Upside

+289.9%

Consensus $2.15 vs current $0.55